0000000000435313

AUTHOR

I. A. Greer

showing 1 related works from this author

Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery

2002

Background Ketorolac is approved for the relief of postoperative pain but concerns have been raised over a possible risk of serious adverse effects and death. Two regulatory reviews in Europe on the safety of ketorolac found the data were inconclusive and lacked comparison with other non-steroidal anti-inflammatory drugs. The aim of this study was to compare the risk of serious adverse effects with ketorolac vs diclofenac or ketoprofen in adult patients after elective major surgery. Methods This prospective, randomized multicentre trial evaluated the risks of death, increased surgical site bleeding, gastrointestinal bleeding, acute renal failure, and allergic reactions, with ketorolac vs di…

AdultMaleKetoprofenGastrointestinal bleedingmedicine.medical_specialtyDiclofenacAnalgesicBlood Loss Surgicallaw.inventionDrug HypersensitivityDiclofenacRandomized controlled trialRisk FactorslawmedicineHumansCyclooxygenase InhibitorsProspective StudiesAdverse effectAgedAged 80 and overPain Postoperativebusiness.industryAnti-Inflammatory Agents Non-SteroidalAnticoagulantsAcute Kidney InjuryMiddle Agedmedicine.diseaseSurgerybody regionsKetorolacClinical trialstomatognathic diseasesAnesthesiology and Pain MedicineKetoprofenAnesthesiaFemalebusinessKetorolacmedicine.drug
researchProduct